Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bevacizumab for advanced breast cancer: all tied up with a RIBBON?

× No keyword cloud information.

19 in total

1. Weighed, measured, and still searching: bevacizumab in the treatment of unselected patients with advanced breast cancer.

Authors: Gilberto Lopes; Rebecca Dent
Journal: Oncologist Date: 2011-12-08

Review 2. The value of progression-free survival to patients with advanced-stage cancer.

Authors: Lesley J Fallowfield; Anne Fleissig
Journal: Nat Rev Clin Oncol Date: 2011-10-18 Impact factor: 66.675

3. Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.

Authors: Wenlian Zhu; Yoshinori Kato; Dmitri Artemov
Journal: MAGMA Date: 2013-06-27 Impact factor: 2.310

Review 4. Reappraising antiangiogenic therapy for breast cancer.

Authors: Robert S Kerbel
Journal: Breast Date: 2011-10 Impact factor: 4.380

5. Targeted therapies: peaking beneath the surface of recent bevacizumab trials.

Authors: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Lee M Ellis
Journal: Nat Rev Clin Oncol Date: 2011-04-19 Impact factor: 66.675

6. Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.

Authors: B Ramaswamy; W Fiskus; B Cohen; C Pellegrino; D L Hershman; E Chuang; Thehang Luu; G Somlo; M Goetz; R Swaby; C L Shapiro; V Stearns; P Christos; I Espinoza-Delgado; K Bhalla; J A Sparano
Journal: Breast Cancer Res Treat Date: 2011-12-27 Impact factor: 4.872

7. Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.

Authors: Eldrid Borgan; Evita M Lindholm; Siver Moestue; Gunhild M Mælandsmo; Ole Christian Lingjærde; Ingrid S Gribbestad; Anne-Lise Børresen-Dale; Olav Engebraaten; Therese Sørlie
Journal: Mol Oncol Date: 2012-10-23 Impact factor: 6.603

8. Targeting angiogenesis in metastatic breast cancer.

Authors: Sangeetha Reddy; Michael Raffin; Virginia Kaklamani
Journal: Oncologist Date: 2012-07-27

9. Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.

Authors: Bryan P Schneider; Robert J Gray; Milan Radovich; Fei Shen; Gail Vance; Lang Li; Guanglong Jiang; Kathy D Miller; Julie R Gralow; Maura N Dickler; Melody A Cobleigh; Edith A Perez; Tamara N Shenkier; Kirsten Vang Nielsen; Sven Müller; Ann Thor; George W Sledge; Joseph A Sparano; Nancy E Davidson; Sunil S Badve
Journal: Clin Cancer Res Date: 2013-01-22 Impact factor: 12.531

Review 10. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.

Authors: Asmaa E El-Kenawi; Azza B El-Remessy
Journal: Br J Pharmacol Date: 2013-10 Impact factor: 8.739